These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 22283470

  • 1. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, Sun M, Li Z, Hou Y, Zhou X, Lou G, Li K.
    Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
    [Abstract] [Full Text] [Related]

  • 2. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
    Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao F, Zhang W, Ke C, Zhang G, Hou Y, Zhou X, Lou G, Li K.
    Clin Chim Acta; 2012 May 18; 413(9-10):861-8. PubMed ID: 22309680
    [Abstract] [Full Text] [Related]

  • 3. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.
    Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, Zhang W, Zhang H, Zhao F, Zhou X, Lou G, Li K.
    J Proteome Res; 2013 Jan 04; 12(1):505-12. PubMed ID: 23163809
    [Abstract] [Full Text] [Related]

  • 4. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.
    Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL.
    Int J Cancer; 2005 Feb 20; 113(5):782-8. PubMed ID: 15499633
    [Abstract] [Full Text] [Related]

  • 5. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
    Shao X, Wang K, Liu X, Gu C, Zhang P, Xie J, Liu W, Sun L, Chen T, Li Y.
    Clin Chim Acta; 2016 Dec 01; 463():200-206. PubMed ID: 27784637
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
    Pylväs M, Puistola U, Laatio L, Kauppila S, Karihtala P.
    Anticancer Res; 2011 Apr 01; 31(4):1411-5. PubMed ID: 21508394
    [Abstract] [Full Text] [Related]

  • 7. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G, Orengo AM, Mezzanzanica D, Bagnoli M, Brizzolara A, Emionite L, Puppo A, Centurioni MG, Bruzzone M, Marroni P, Rossello A, Canevari S, Ferrini S, Fabbi M.
    Int J Cancer; 2013 Jun 01; 132(11):2597-605. PubMed ID: 23169448
    [Abstract] [Full Text] [Related]

  • 8. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L, Hogdall C.
    Acta Obstet Gynecol Scand; 2009 Jun 01; 88(1):18-26. PubMed ID: 19023702
    [Abstract] [Full Text] [Related]

  • 9. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW.
    Clin Cancer Res; 2006 Jan 15; 12(2):432-41. PubMed ID: 16428483
    [Abstract] [Full Text] [Related]

  • 10. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y, Zhang R, Song Y, He J, Sun J, Bai J, An Z, Dong L, Zhan Q, Abliz Z.
    Analyst; 2009 Oct 15; 134(10):2003-11. PubMed ID: 19768207
    [Abstract] [Full Text] [Related]

  • 11. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C, Liang QL, Hu P, Wang YM, Luo GA.
    Talanta; 2011 Sep 30; 85(4):1711-20. PubMed ID: 21872008
    [Abstract] [Full Text] [Related]

  • 12. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
    Zhang H, Ge T, Cui X, Hou Y, Ke C, Yang M, Yang K, Wang J, Guo B, Zhang F, Lou G, Li K.
    Mol Biosyst; 2015 Feb 30; 11(2):516-21. PubMed ID: 25424060
    [Abstract] [Full Text] [Related]

  • 13. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W.
    J Proteome Res; 2012 Feb 03; 11(2):1354-63. PubMed ID: 22148915
    [Abstract] [Full Text] [Related]

  • 14. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct 01; 877(27):3111-7. PubMed ID: 19716777
    [Abstract] [Full Text] [Related]

  • 15. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
    Wu WJ, Wang Q, Zhang W, Li L.
    Zhonghua Zhong Liu Za Zhi; 2017 Dec 23; 39(12):896-902. PubMed ID: 29262505
    [Abstract] [Full Text] [Related]

  • 16. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX, Wu Y, Han HQ, Wang QH.
    Ai Zheng; 2003 Jan 23; 22(1):58-61. PubMed ID: 12561438
    [Abstract] [Full Text] [Related]

  • 17. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
    Zhang F, Zhang Y, Ke C, Li A, Wang W, Yang K, Liu H, Xie H, Deng K, Zhao W, Yang C, Lou G, Hou Y, Li K.
    Metabolomics; 2018 Apr 26; 14(5):65. PubMed ID: 30830339
    [Abstract] [Full Text] [Related]

  • 18. Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.
    Li J, Xie H, Li A, Cheng J, Yang K, Wang J, Wang W, Zhang F, Li Z, Dhillon HS, Openkova MS, Zhou X, Li K, Hou Y.
    Oncotarget; 2017 Jul 18; 8(29):46834-46845. PubMed ID: 27564116
    [Abstract] [Full Text] [Related]

  • 19. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.
    Schock H, Surcel HM, Zeleniuch-Jacquotte A, Grankvist K, Lakso HÅ, Fortner RT, Kaaks R, Pukkala E, Lehtinen M, Toniolo P, Lundin E.
    Endocr Relat Cancer; 2014 Jul 18; 21(6):831-44. PubMed ID: 25270324
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ, Qi J, Wang H, Li XX, Wei BJ, Fu C, Gao J, Han BB.
    Zhonghua Zhong Liu Za Zhi; 2011 Jul 18; 33(7):540-3. PubMed ID: 22093635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.